Key result
CaMKII inhibition with KN-93 ameliorated doxorubicin-induced cardiac dysfunction, endoplasmic reticulum stress, and apoptosis by regulating the IRE1α/XBP1s pathway.
Why the study?
CaMKII is implicated in doxorubicin-induced cardiotoxicity, but whether it exacerbates cardiotoxicity by promoting endoplasmic reticulum stress and apoptosis via the IRE1α/XBP1s pathway remained to be determined.
Does CaMKII inhibition ameliorate doxorubicin-induced cardiotoxicity by regulating endoplasmic reticulum stress and apoptosis in mice and human cardiomyocytes?
Does CaMKII inhibition ameliorate doxorubicin-induced cardiotoxicity by regulating endoplasmic reticulum stress and apoptosis in mice and human cardiomyocytes?
CaMKII inhibition protects against doxorubicin-induced cardiotoxicity by reducing endoplasmic reticulum stress and apoptosis via the IRE1α/XBP1s pathway, highlighting a potential therapeutic target for chemotherapy-induced heart failure.
Answers are grounded in this paper and cite their sources.
CaMKII-IRE1α/XBP1s targeting remains investigational in doxorubicin cardiotoxicity; leaves open clinical translation pending prospective validation.
/calmodulin-dependent protein kinase II (CaMKII) is implicated in the pathological progression of Dox-induced cardiotoxicity. This study examined the hypothesis that CaMKII exacerbates Dox-induced cardiotoxicity by promoting endoplasmic reticulum stress and apoptosis through regulation of the inositol-requiring enzyme 1α (IRE1α)/spliced X-box binding protein 1 (XBP1s) pathway. Our results demonstrated that CaMKII activation and IRE1α/XBP1s pathway were involved in Dox-treated hearts. CaMKII inhibition with KN-93 ameliorated Dox-induced cardiac dysfunction and pathological myocardial changes. In addition, CaMKII inhibition prevented Dox-induced endoplasmic reticulum stress and apoptosis. Moreover, CaMKII inhibition increased the expression of IRE1α and XBP1s in Dox-treated hearts. The IRE1α inhibitor 4μ8C blocked the protective effect of CaMKII inhibition against Dox-induced cardiotoxicity. Mechanistically, 4μ8C prevented the effects of CaMKII inhibition on Dox-induced endoplasmic reticulum stress and apoptosis by inhibiting the expression of IRE1α and XBP1s. Additionally, treatment with rhADAMTS13 decreased the protein level of thrombospondin 1 (TSP1) and the phosphorylation of CaMKII in Dox-treated human AC16 cardiomyocytes. Taken together, these results demonstrate that the ADAMTS13-TSP1 axis regulates CaMKII activation and exacerbates Dox-induced cardiotoxicity by triggering endoplasmic reticulum stress and apoptosis by inhibiting the IRE1α/XBP1s pathway.
No takes yet. Share an insight, caveat, or question.
Kong et al. (2022) studied Doxorubicin-induced cardiotoxicity (n=60). KN-93 (CaMKII inhibitor) vs. Doxorubicin alone was evaluated on Cardiac dysfunction and pathological myocardial changes (p=<0.01). CaMKII inhibition with KN-93 ameliorated doxorubicin-induced cardiac dysfunction, endoplasmic reticulum stress, and apoptosis by regulating the IRE1α/XBP1s pathway.
Synapse has enriched 10 related papers. Consider them for comparative context: